Healthcare -
Biotechnology - NASDAQ - US
$ 15.85
5.46 %
$ 482 M
Market Cap
-2.62
P/E
ANAB - REVENUE
Revenue ANAB - AnaptysBio, Inc.
17.2 M
LAST VALUE
-47.89%
2 YEAR CAGR
27.97%
5 YEAR CAGR
12.08%
10 YEAR CAGR